Tamsulosin Assisted Ureteral Access Sheath Insertion

NCT05197088 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-01-19

No results posted yet for this study

Summary

Aim is to study if 1 week of pre operative tamsulosin would enable easier insertion of ureteral access sheath in primary retrograde intrarenal surgery for renal stone disease

Conditions

  • Renal Stone
  • Retrograde Intrarenal Surgery
  • Urolithiasis

Interventions

DRUG

Tamsulosin

1 week of tamsulosin

Sponsors & Collaborators

  • Sengkang General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-09
Primary Completion
2023-03-31
Completion
2023-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05197088 on ClinicalTrials.gov